Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.3572
-0.0260-6.78%
Pre-market: 0.35750.0003+0.08%06:05 EDT
Volume:643.43K
Turnover:237.79K
Market Cap:11.86M
PE:-0.13
High:0.3892
Open:0.3801
Low:0.3522
Close:0.3832
Loading ...
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 07, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Dec 08, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2020

Major Issues Report

8-K - Current report
Aug 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 11, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2020

Major Issues Report

8-K - Current report
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 06, 2020

Major Issues Report

[Amend] Current report, item 5.02
Mar 12, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Mar 09, 2020

Major Issues Report

Current report, items 1.01, 5.07, and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals